nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advanced therapy medicinal products: Regulatory framework, hospital and pharmaceutical circuits in Europe and France
|
Mebarki, Miryam |
|
|
77 |
2 |
p. 185-190 |
artikel |
2 |
Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase®
|
Strumia, Mathilde |
|
|
77 |
2 |
p. 219-227 |
artikel |
3 |
Editorial board
|
|
|
|
77 |
2 |
p. i |
artikel |
4 |
From cardio-oncology to cardio-onco-pharmacology: Towards a multidisciplinary approach in the understanding and management of cardiotoxicity
|
Ederhy, Stéphane |
|
|
77 |
2 |
p. 197-206 |
artikel |
5 |
Hemato-oncopharmacology: Drugs and cancer
|
Kiladjian, Jean-Jacques |
|
|
77 |
2 |
p. 149-150 |
artikel |
6 |
Immunotherapies in acute leukemia
|
Boissel, Nicolas |
|
|
77 |
2 |
p. 241-250 |
artikel |
7 |
Of some innovations in clinical trial design in hematology and oncology
|
Lévy, Vincent |
|
|
77 |
2 |
p. 191-195 |
artikel |
8 |
Pharmacoepidemiology for oncology clinical practice: Foundations, state of the art and perspectives
|
de Germay, Sibylle |
|
|
77 |
2 |
p. 229-240 |
artikel |
9 |
Pharmacogenomics in solid cancers and hematologic malignancies: Improving personalized drug prescription
|
Maillard, Maud |
|
|
77 |
2 |
p. 171-183 |
artikel |
10 |
Pharmacokinetics and therapeutic drug monitoring of anticancer protein/kinase inhibitors
|
Bouchet, Stéphane |
|
|
77 |
2 |
p. 157-170 |
artikel |
11 |
Pharmacology and pharmacovigilance of protein kinase inhibitors
|
Khouri, Charles |
|
|
77 |
2 |
p. 207-217 |
artikel |
12 |
The challenge of targets and drug discovery using large-scale screening approaches in onco-hematology
|
Benajiba, Lina |
|
|
77 |
2 |
p. 151-155 |
artikel |
13 |
The “old” cytotoxic drugs, the basis of anti-cancer treatments
|
Manfredi, Sylvain |
|
|
77 |
2 |
p. 251-255 |
artikel |